David Rokach - Nukkleus COO Director
| NUKKDelisted Stock | USD 2.06 0.11 5.64% |
Director
David Rokach is COO Director of Nukkleus
| Age | 56 |
| Phone | 212 791 4663 |
| Web | https://www.nukk.com |
Nukkleus Management Efficiency
The company has return on total asset (ROA) of (3.973) % which means that it has lost $3.973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities.Nukkleus currently holds 4 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Nukkleus' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 8 records | DIRECTOR Age | ||
| Frank Stansberry | Marketwise | 53 | |
| Asad Ghauri | NetSol Technologies | 49 | |
| Malea Farsai | NetSol Technologies | 55 | |
| Angela Diaco | Aware Inc | N/A | |
| Jeremy Krol | Phunware | 48 | |
| Malea JD | NetSol Technologies | 55 | |
| Stephen Chen | Phunware | 42 | |
| Omar Ghauri | NetSol Technologies | N/A | |
Management Performance
| Return On Equity | -7.42 | ||||
| Return On Asset | -3.97 |
Nukkleus Leadership Team
Elected by the shareholders, the Nukkleus' board of directors comprises two types of representatives: Nukkleus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nukkleus. The board's role is to monitor Nukkleus' management team and ensure that shareholders' interests are well served. Nukkleus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nukkleus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jamal Khurshid, COO Director | ||
| Emil Assentato, President CEO, Treasurer, Secretary, Director | ||
| Yair Ohayon, Investor Officer | ||
| Menachem Shalom, CEO Director | ||
| Morel Levi, Chief Officer | ||
| Andrew MBA, Chief Officer | ||
| Shawn Dilkes, Chief Officer | ||
| David Rokach, COO Director |
Nukkleus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nukkleus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.42 | ||||
| Return On Asset | -3.97 | ||||
| Current Valuation | 46.16 M | ||||
| Shares Outstanding | 25.27 M | ||||
| Shares Owned By Insiders | 24.73 % | ||||
| Shares Owned By Institutions | 5.84 % | ||||
| Number Of Shares Shorted | 2.91 M | ||||
| Price To Earning | (40.00) X | ||||
| Price To Book | 0.69 X | ||||
| Price To Sales | 0.60 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Nukkleus Stock
If you are still planning to invest in Nukkleus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nukkleus' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |